The Effects of Active Hexose Correlated Compound (AHCC) on Levels of CD4+ and CD8+ in Patients with Epithelial Ovarian Cancer or Peritoneal Cancer Receiving Platinum Based Chemotherapy

BACKGROUND: Adjuvant chemotherapy is a required treatment for most patients with epithelial ovarian cancer (EOC) or peritoneal cancer. However, it has many adverse events which may affect oncologic outcomes. Active hexose correlated compound (AHCC) has been reported to be an immunoenhancer to decrea...

Descripción completa

Detalles Bibliográficos
Autores principales: Suknikhom, Wineeya, Lertkhachonsuk, Ruangsak, Manchana, Tarinee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464477/
https://www.ncbi.nlm.nih.gov/pubmed/28440968
http://dx.doi.org/10.22034/APJCP.2017.18.3.633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464477/
https://www.ncbi.nlm.nih.gov/pubmed/28440968
http://dx.doi.org/10.22034/APJCP.2017.18.3.633

Ejemplares similares